Articles

Prior authorization by the Health Insurance Organizations in Iran

Abstract

Background: Health care improvement has had a critical role in increasing life expectancy throughout the world. The expenditures of research and development and also marketing for new pharmaceutical products are much higher than already existing medicines, resulting in higher prices for the former products. Therefore governments and health insurance organizations are interested in implementing policies that control drug prescription and utilization. One of these policies is Prior Authorization (PA). The main goal of PA is to reduce drug expenditures by substituting expensive medicines with less costly ones. PA policy has both scientific and economical aspects. The aim of this article is to assess the state of implementation of PA policy in Iran. There are several bodies to regulate medicines and their price in Iranian pharmaceutical market. There are two main insurance companies in Iran with similarities and differences in implementing this policy. Price ceiling and Reference Based Pricing are two main methods for implementing PA policy in Iran.

(1) Zasimova L. Public policy and access to new drugs: evidence from

Russian pharmaceutical market, PEI Electronic Publications 2/2010.

(2) The Henry J. Kaiser Family Foundation, Prescription Drug Trends, May

(3) Lapenesee KT. Analysis of a Prescription Drug Prior Authorization

Program in a Medicaid Health Maintenance Organization, J

Managed Care Pharm.2003; 9(1): 36-44.

(4) OECD. OECD Health Data 2006: Statistics and indicators for 30

countries. Paris: OECD, 2006.

(5) Mary Beth Hamel, Arnold M. Epstein, Prior-Authorization Programs

for Controlling Drug Spending. N Engl J Med. 2004; 351; 21.

(6) Comprehenive guide in Pharmacies, Davood Feyzi, Mahnaz

Mazandarani, Rouzbahan Press, p155-136, 2012.

(7) Puig-Junoy J, Moreno-Torres I. Impact of pharmaceutical prior

authorization policies; a systematic review of the literature.

Pharmacoeconomics. 2007; 25 (8):637-648.

Files
IssueVol 1 No 3/4 (2015) QRcode
SectionArticles
Keywords
Prior Authorization Insurance organization Drug expenditure Medicines’ price.
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Kheirandish M, Gharibnaseri Z, Soleymani F, Kebriaeezadeh A. Prior authorization by the Health Insurance Organizations in Iran. JPPM. 2015;1(3/4):59-60.